To support the search for, and development of, new technology to bring the COVID-19 pandemic to an end, Irish higher education institutes have agreed to provide their cutting edge intellectual property, free of charge, to companies engaged in critical research and development activities for the sole purpose of diagnosing, preventing, containing, treating and/or minimising the impact of the COVID-19 virus.
To access critical intellectual property held by Irish universities and institutes of technology that is needed by companies in the battle against COVID-19, Knowledge Transfer Ireland (KTI) (the national office that supports research commercialisation) and the Technology Transfer Offices at a number of Irish universities and institutes of technology have created a simple (2 page) COVID-19 Non-Exclusive Royalty-free Licence (NERF Licence) which companies can use.
The COVID-19 NERF Licence will remain in place until such time as the World Health Organization declares the current pandemic to have ended.
The new COVID-19 NERF Licence is available from the KTI website.The KTI website also contains information on, and links to, the various higher education institutes and the research they are undertaking.
For more information please contact Maureen Daly (Intellectual Property).
To discuss any other COVID-19 related issues impacting your business, please get in touch with Damian Maloney (Corporate and Commercial), Edward Evans (Corporate & Commercial), Gerry Gallen (Commercial Property), Sandra Masterson Power (Employment), Paul Gough (Employment), Dorit McCann (EU, Competition & Procurement), Fidelma McManus (Housing), Barry Cahir (Litigation and Insolvency), Thomas O'Dwyer (Litigation), Sharon Delaney (Litigation), or your usual Beauchamps contact.